首页> 美国卫生研究院文献>Cell Death Disease >LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1
【2h】

LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1

机译:LNCRNA SNHG15通过海绵MIR-451调节肺腺癌中获得的抗性通过海绵MIR-451上调MDR-1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

a IC50 of A549, H1975, A549/GR, and H1975/GR was detected. b qRT-PCR was conducted to investigate the expression of signaling pathway receptors (NOTCH-1, NOTCH-2, NOTCH-3, and NOTCH-4) and ligands (Jagged-1, Jagged-2, and Delta-1) in human lung adenocarcinoma cells (A549 and H1975) and their relevant drug-resistant cell lines (A549/GR and H1975/GR). c The protein level of NOTCH-1was tested via western blot. d The alteration of SNHG15 expression caused by sh-NOTCH-1 was tested in A549/GR and H1975/GR via qRT-PCR. e qRT-PCR was used to test the interference efficiency of SNHG15. f–i The proliferation, apoptosis, and cell cycle of A549/GR and H1975/GR were investigated by colony formation assay, EdU assay and flow cytometry analysis. Data obtained from three replications were shown as mean ± S.D. *P < 0.05, **P < 0.01 indicated that differences were statistically significant.
机译:检测到A549,H1975,A549 / G和H1975 / GR的IC50。进行B QRT-PCR以研究人体中的信号通路受体(Notch-1,Notch-2,Notch-3和Notch-4)和配体(锯齿状-1,锯齿状-2和Delta-1)的表达肺腺癌细胞(A549和H1975)及其相关的耐药细胞系(A549 / GR和H1975 / GR)。 c通过蛋白质印迹测试的Notch-1族蛋白质水平。 d通过QRT-PCR在A549 / GR和H1975 / GR中测试SH-Notch-1引起的SNHG15表达的改变。 E QRT-PCR用于测试SNHG15的干扰效率。通过菌落形成测定,EDU测定和流式细胞术分析研究了A549 / GR和H1975 / GR的增殖,细胞凋亡和细胞周期。从三种复制获得的数据显示为平均值±S.D. * P <0.05,** P <0.01表明差异有统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号